Lantheus Holdings, Inc.

LNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 2, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
S-8 Sep 2, 2026 S-8
PREM14A Aug 26, 2026 PREM14A
4 Aug 19, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 19, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
DEFA14A Aug 13, 2026 DEFA14A
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
DEFA14A Aug 4, 2026 DEFA14A
DEFA14A Aug 4, 2026 DEFA14A
8-K Aug 4, 2026 8-K
DEFA14A Aug 3, 2026 DEFA14A
DEFA14A Aug 3, 2026 DEFA14A
8-K Aug 3, 2026 8-K
SCHEDULE 13G Jul 31, 2026
4 Jun 3, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jun 3, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
SD May 29, 2026 SD
4 May 18, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
← Newer Page 2 of 45 · 1125 filings Older →